Apoptosis of alveolar wall cells in chronic obstructive pulmonary disease patients with pulmonary emphysema is involved in emphysematous changes

Abstract

This study explored the role of apoptosis of alveolar wall cells of chronic obstructive pulmonary disease (COPD) patients with pulmonary emphysema in the pathogenesis of emphysema. The subjects were divided into three groups: COPD patients with pulmonary emphysema (COPD group), asymptomatic smokers and non-smokers. Lung tissues were harvested and histologically assessed. TUNEL assay was employed to determine the apoptotic cells. The expression of PCNA, Bax and SP-C in the lung alveolar wall cells were immunohistochemically determined. SP-C immunofluorescence staining was used to identify type II alveolar cells in the TUNEL-positive cells. The mean linear interval (MLI), mean alveoli number (MAN) and mean alveoli area (MAA) in COPD group were significantly different as compared with those in asymptomatic smokers and non-smokers, respectively (P<0.01). The proliferation index (PI), apoptosis index (AI) and the percentage of Bax-positive cells in COPD group were significantly greater than those of asymptomatic smokers and non-smokers (P<0.01). However, the percentage of SP-C-positive cells was significantly lower in COPD group than in asymptomatic smokers and non-smokers (P<0.01). Most of the TUNEL-positive cells expressed SP-C. In COPD group, the apoptosis of alveolar wall cells, especially apoptosis of type-II cells, may take part in the pathogenesis of emphysema. Up-regulation of Bax expression may be responsible for the apoptosis of alveolar wall cells in the COPD patients with pulmonary emphysema.

Keywords

emphysema / apoptosis / proliferation

References

[1] BarnesP.J., ShapiroS.D., PauwelsR.A.. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J, 2003, 22(4): 672-688

[2] KasaharaY., TuderR.M., CoolC.D., et al.. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med, 2001, 163(3Pt1): 737-744

[3] KasaharaY., TuderR.M., Taraseviciene-StewartL., et al.. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest, 2000, 106(11): 1311-1319

[4] ShapiroS.D.. Vascular atrophy and VEGFR-2 signaling: old theories of pulmonary emphysema meet new data. J Clin Invest, 2000, 106(11): 1309-1310

[5] AoshibaK., YokohoriN., NagaiA.. Alveolar wall apoptosis induces lung destruction and emphysematous changes. Am J Respir Cell Mol Biol, 2003, 28(5): 555-562

[6] TuderR.M., McGrathS., NeptuneE.. The pathobiological mechanisms of emphysema models: what do they have in common?. Pulm Pharmacol Ther, 2003, 16(2): 67-78

[7] TuderR.M., YoshidaT., ArapW., et al.. State of the art: cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc, 2006, 3(6): 503-510

[8] RahmanI., KiltyI.. Antioxidant therapeutic targets in COPD. Curr Drug Targets, 2006, 7(6): 707-720

[9] YangS.R., ChidaA.S., BauterM.R., et al.. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol, 2006, 291: L46-L57

[10] StollerJ.K., AboussouanL.S.. Alpha1-antitrypsin deficiency. Lancet, 2005, 365(9478): 2225-2236

[11] PapaioannouA.I., KostikasK., KolliaP., et al.. Clinical implications for vascular endothelial growth factor in the lung: friend or foe?. Respir Res, 2006, 7: 128

[12] Segura-ValdezL., PardoA., GaxiolaM., et al.. Upregulation of gelatinases A and B, collagenases 1 and 2, and ncreased parenchymal cell death in COPD. Chest, 2000, 117(3): 684-694

[13] ImaiK., MercerB.A., SchulmanL.L., et al.. Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Respir J, 2005, 25(2): 250-258

[14] YokohoriN., AoshibaK., NagaiA.. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest, 2004, 125(22): 626-632

[15] HodgeS., HodgeG., HolmesM., et al.. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur Respir J, 2005, 25(3): 447-454

[16] KasaharaY., TuderR.M., CoolC.D., et al.. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med, 2001, 163(3Pt1): 737-744

[17] KanazawaH., YoshikawaJ.. Elevated oxidative stress and reciprocal reduction of vascular endothelial growth factor levels with severity of COPD. Chest, 2005, 128(5): 3191-3197

[18] AoshibaK., YokohoriN., NagaiA.. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol, 2003, 28(5): 555-562

[19] PetracheI., NatarajanV., ZhenL., et al.. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med, 2005, 11(5): 491-498

[20] TangK., RossiterH.B., WagnerP.D., et al.. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol, 2004, 97(4): 1559-1566

[21] ImaiK., MercerB.A., SchulmanL.L., et al.. Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Respir J, 2005, 25(2): 250-258

[22] SuzukiT., MoraesT.J., VachonE., et al.. proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells. Am J Respir Cell Mol Biol, 2005, 33(3): 231-247

[23] HedyH.G., PatrickT.S., TomokoS., et al.. Leukocyte elastase induces epithelial apoptosis: role of mitochondial permeability changes and Akt. Am J Physiol Gastrointest Liver Physiol, 2004, 287(1): 286-298

[24] NakajohM., FukushimaT., SuzukiT., et al.. Retinoic acid inhibits elastase-induced injury in human lung epithelial cell lines. Am J Respir Cell Mol Biol, 2003, 28(3): 296-304

[25] ClarkH., ReidK.. The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema. Arch Dis Child, 2003, 88(11): 981-984